Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 0 | 0 | 143,962 | 140,195 | 132,895 |
| Gross Profit | N/A | N/A | 77,090 | 139,260 | 132,890 |
| Operating Expenses | 4,012 | 0 | 0 | 0 | 0 |
| Operating Income | -4,012 | N/A | 143,962 | 140,195 | 132,895 |
| Other Income | 93 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -3,919 | 0 | 143,962 | 140,195 | 132,895 |
| Income Tax | 14 | N/A | 0 | 0 | 0 |
| Net Income Continuous | -3,933 | N/A | -2,336 | -661 | -1,680 |
| Net Income Discontinuous | N/A | N/A | 81 | 692 | -826 |
| Net Income | $-3,933 | $N/A | $-2,255 | $31 | $-2,506 |
| EPS Basic Total Ops | -2.10 | N/A | -0.27 | 0.00 | -0.30 |
| EPS Basic Continuous Ops | -2.10 | N/A | -0.28 | -0.08 | -0.20 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.01 | 0.08 | -0.10 |
| EPS Diluted Total Ops | -2.10 | N/A | -0.27 | 0.00 | -0.30 |
| EPS Diluted Continuous Ops | -2.10 | N/A | -0.28 | N/A | -0.20 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.01 | N/A | -0.10 |
| EBITDA(a) | $-3,949 | $N/A | $144,822 | $140,105 | $134,195 |